Ovid Therapeutics Inc. - 10-Q Filing
Ovid Therapeutics filed a Form 10-Q for the quarter ended March 31, 2026. The filing includes financial data and disclosures related to equity transactions such as preferred stock issuances under a private placement in October 2025, warrants issued with Series A and B Preferred Stock, and subsequent events including warrant expirations and share price volatility inputs.
Tickers: $OVID